课题基金 / 基金详情

LASP1 as a functional linker protein between cadherin and actin dynamics at epithelial adherens junctions

LASP1 as a functional linker protein between cadherin and actin dynamics at epithelial adherens junctions
LASP1 作为上皮粘附连接处钙粘蛋白和肌动蛋白动力学之间的功能性连接蛋白
批准号:
414058881
负责人:
Professor Dr. Hans-Joachim Schnittler
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2022-12-31

项目摘要

项目成果

Professor Dr. Hans-Joachim Schnittler的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epithelial cadherin (E-cadherin) mediates epithelial adhesion and connects via the beta-catenin/alpha-catenin complex to the actin cytoskeleton that in turn contributes to adherence junction organization and dynamics. Epithelia display an organ-specific Phenotype that is beyond tight junctions largely determine by adherens junctions. We postulate that the supramolecular organization of adherens junctions has a significant impact on the organization and function of AJs. Similarly, we suspect that the expression of mesenchymal cadherins such as VE-cadherin and cadherin-11 during EMT alters the supramolecular organization of AJs, thereby contributing to an altered cell-junction dynamics of carcinomas. Recently we found a novel mechanism of junction regulation in endothelium, which is based on actin-driven junction-associated intermittent lamellipodia (JAIL). JAIL drive VE-cadherin dynamics and thus controls adhesion features, cell migration and monolayer integrity. Similarily, here we show for the first time that epithelial cell lines and human breast carcinoma cell lines display comparable JAIL-like structures. Furthermore, AJ organization and dynamics is controlled by actin-binding and cadherin regulating proteins together with signaling molecules involving acto-myosin mediated contractility. In this context, we identified the LIM and SH3 protein 1 (LASP1), an actin binding protein, as a component of epithelial adherens junctions, and found it overexpressed in dedifferentiated breast cancer MDA cell lines as well as in chronically inflamed tissue, situations in which alterations in cell-to-cell adhesion plays a central role. Furthermore, we identified LASP1 as a new binding partner for β-catenin, which localizes at epithelial adherens junctions and interestingly in JAIL-like plasma membrane protrusion. Mechanistically, we propose LASP1 as a novel adherens junction associated protein in epithelium, which in concerted interaction with actin and b-catenin contributes to junction organization and dynamics. To test the impact of LASP1 and ectopically expressed cadherins on adherens junction dynamics, we will investigate different differentiated MDCK cell lines and human breast cancer cell lines that ectopic express cadherin-11 and VE-cadherin. Fluorescence tagged adherens junction and cytoskeletal proteins will be expressed and fluorescence-based life cell imaging performed to quantitatively monitor cadherin and actin dynamics. Data will be complemented by superresolution microscopy to characterize the supramolecular organization of adherens junctions in a cadherin and LASP1 dependent manner along with established cell- and molecular biology techniques. We plan to use a CHO expression system for confirmation of particular interactions. We expect to establish a molecular mechanistic model that helps to explain the differentiation dependent control of epithelial adherens junction dynamics in physiology, and in EMT and tumor development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Organization and dynamics of subcellular functional domains as regulators of endothelial cell junctions
Molecular mechanisms of caveolin-1 controlled infection of endothelial cells by Influenza A and Ebola viruses
Koordination des Schwerpunktprogramms
Differentielle Funktionen der Komponenten des VE-Cadherin/Catenin-Komplexes und der VE-Cadherin-Glykosylierung des vaskulären Endothels
国内基金
海外基金
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
  • 批准号:
    82371873
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    乔洁
  • 依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    沃雁
  • 依托单位: